FDA Inspection 1265141 — RIPPLEVERSE CORPORATION
The FDA completed an inspection of RIPPLEVERSE CORPORATION on March 20, 2025 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 20, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Irving, TX (United States)